Tumor necrosis factor/cachectin induces a wide variety of biological effects on cell growth and differentiation. This cytokine, synthesized from macrophages and lymphocytes, not only exhibits cytotoxic properties, but also stimulates cell proliferation, and is involved in different pathological conditions including septic shock, rheumatoid arthritis, autoimmunity, HIV gene expression, and cachexia. Although the actions of TNF-alpha appear to be mediated by two specific receptors of Mr of 55,000 and 75,000, little is known about how binding to these two receptors stimulates cells to respond appropriately. Additionally, the precise molecular signal transduction mechanisms that account for the many biological effects of TNF-alpha have not been defined. Other polypeptide growth factors such as EGF, PDGF, insulin, and NGF convey their signals across the cell membrane by stimulating specific phosphorylation events after ligand binding. The TNF receptors share similar extracellular domains with the p75 NGF receptor and several B and T cell surface molecules, however, the intracellular domains are unique and unrelated to any other known protein. We shall test the hypothesis that TNF-alpha action must require additional signalling molecules, in concert with the recently cloned receptors in order to be functionally active. These studies will ultimately elucidate the molecular mechanisms that are responsible for TNF-alpha action during normal and disease states.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056490-03
Application #
2097348
Study Section
Metabolic Pathology Study Section (MEP)
Project Start
1992-04-10
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1996-03-31
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Arevalo, Juan Carlos; Pereira, Daniela B; Yano, Hiroko et al. (2006) Identification of a switch in neurotrophin signaling by selective tyrosine phosphorylation. J Biol Chem 281:1001-7
Zampieri, Niccolo; Xu, Chong-Feng; Neubert, Thomas A et al. (2005) Cleavage of p75 neurotrophin receptor by alpha-secretase and gamma-secretase requires specific receptor domains. J Biol Chem 280:14563-71
Chittka, Alexandra; Arevalo, Juan Carlos; Rodriguez-Guzman, Maria et al. (2004) The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E. J Cell Biol 164:985-96
Murray, Simon S; Perez, Pilar; Lee, Ramee et al. (2004) A novel p75 neurotrophin receptor-related protein, NRH2, regulates nerve growth factor binding to the TrkA receptor. J Neurosci 24:2742-9
Jung, Kwang-Mook; Tan, Serena; Landman, Natalie et al. (2003) Regulated intramembrane proteolysis of the p75 neurotrophin receptor modulates its association with the TrkA receptor. J Biol Chem 278:42161-9
Kim, Albert H; Sasaki, Takehiko; Chao, Moses V (2003) JNK-interacting protein 1 promotes Akt1 activation. J Biol Chem 278:29830-6
Kim, Albert H; Yano, Hiroko; Cho, Han et al. (2002) Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron 35:697-709
Khursigara, G; Bertin, J; Yano, H et al. (2001) A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci 21:5854-63
Dowling, P; Ming, X; Raval, S et al. (1999) Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology 53:1676-82
Orlinick, J R; Vaishnaw, A; Elkon, K B et al. (1997) Requirement of cysteine-rich repeats of the Fas receptor for binding by the Fas ligand. J Biol Chem 272:28889-94

Showing the most recent 10 out of 15 publications